0000950170-23-029702.txt : 20230623
0000950170-23-029702.hdr.sgml : 20230623
20230623200646
ACCESSION NUMBER: 0000950170-23-029702
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yale Catriona
CENTRAL INDEX KEY: 0001779308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 231039222
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS INC.
STREET 2: 170 HARBOR WAY 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
ownership.xml
4
X0407
4
2023-06-21
0001744659
Akero Therapeutics, Inc.
AKRO
0001779308
Yale Catriona
C/O AKERO THERAPEUTICS, INC.
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Development Officer
false
Common Stock
2023-06-21
4
S
false
11349
52.2597
D
68627
D
Common Stock
2023-06-22
4
S
false
11000
52.1759
D
57627
D
Common Stock
2023-06-23
4
S
false
10500
50.7291
D
47127
D
Common Stock
2023-06-23
4
S
false
500
51.4087
D
46627
D
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $52.08 to $52.7125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.81, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $51.16, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $51.28 to $51.50, inclusive.
/s/ Jonathan Young, Attorney-in-Fact
2023-06-23